Physician profile
Alice Wang
NPI 1992210660
$1,271.52
in general payments reported to CMS, 2019-2025
16 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $315 · 2024: $683 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,271.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $238.79 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Regeneron Healthcare Solutions, INC. | $149.00 | 2023 | Libtayo |
| Abbvie INC. | $147.95 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $132.03 | 2023-2025 | Airsupra, Farxiga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $131.46 | 2023-2024 | Xifaxan |
| Lilly USA, LLC | $117.05 | 2024 | Mounjaro, Zepbound, Emgality |
| Amgen INC. | $76.65 | 2024-2025 | Otezla, Repatha, Repatha |
| Pfizer INC. | $56.32 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $38.51 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Glaxosmithkline, LLC. | $37.22 | 2024-2025 | Shingrix, Arexvy |
| Inari Medical, INC. | $32.85 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Corcept Therapeutics | $27.13 | 2025 | Korlym |
| Exact Sciences Corporation | $25.85 | 2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $24.34 | 2024 | Veozah |
| Bausch Health US, LLC | $21.54 | 2024 | Aplenzin |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $14.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.